With CE mark clearance, our MyoVista global launch initiatives currently include several countries in the following Regions: Asia Pacific, Latin America, Canada, Europe and the Middle East. This focused strategy enables us to effectively lead a successful international sales and distribution market release of MyoVista Device for healthcare providers in select countries anticipated in 2017. Thereafter HeartSciences will continue to execute a defined global roll out in other select countries in 2018.
Should you have interest in obtaining periodic updates on MyoVista Device distribution and our international launch progress, please click here to fill out and remit our online International Distributor Inquiry Form.
For all other general inquiries about distribution in your region, please contact Sales Operations at email@example.com.